{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:04:19Z","timestamp":1791374659103,"version":"4.3.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.jocn.2007.09.016","type":"journal-article","created":{"date-parts":[[2008,7,24]],"date-time":"2008-07-24T09:18:09Z","timestamp":1216891089000},"page":"1031-1035","source":"Crossref","is-referenced-by-count":48,"title":["Increased levels of activated T-cells and reduced levels of CD4\/CD25+ cells in peripheral blood of Guillain-Barr\u00e9 syndrome patients compared to controls"],"prefix":"10.1016","volume":"15","author":[{"given":"J.","family":"Harness","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.A.","family":"McCombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.jocn.2007.09.016_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ana.410090703","article-title":"Diagnostic considerations in Guillain-Barr\u00e9 syndrome","volume":"9","author":"Asbury","year":"1981","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2007.09.016_bib2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-5728(99)00195-2","article-title":"Pathogenesis of Guillain-Barre syndrome","volume":"100","author":"Hughes","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2007.09.016_bib3","first-page":"448","article-title":"Lymphocyte subpopulations and suppressor cell activity in acute polyradiculoneuritis (Guillain-Barr\u00e9 syndrome)","volume":"51","author":"Hughes","year":"1983","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jocn.2007.09.016_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-5728(85)80050-3","article-title":"Circulating T-cell subsets in Guillain-Barr\u00e9 syndrome","volume":"8","author":"Lisak","year":"1985","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2007.09.016_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0165-5728(94)90032-9","article-title":"T lymphocyte subset abnormalities in peripheral blood from patients with the Guillain-Barre syndrome","volume":"53","author":"Dahle","year":"1994","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2007.09.016_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0022-510X(97)00082-8","article-title":"A longitudinal study of circulating lymphocyte subsets in the peripheral blood during the acute stage of Guillain-Barre syndrome","volume":"151","author":"Sindern","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2007.09.016_bib7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/oxfordjournals.bmb.a011632","article-title":"Apoptosis and the immune system","volume":"53","author":"Ekert","year":"1997","journal-title":"Br Med Bull"},{"key":"10.1016\/j.jocn.2007.09.016_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s10238-004-0042-3","article-title":"Non-antigen specific CD8+ T suppressor lymphocytes","volume":"4","author":"Filaci","year":"2004","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.jocn.2007.09.016_bib9","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.4049\/jimmunol.166.10.6452","article-title":"Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus","volume":"166","author":"Filaci","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jocn.2007.09.016_bib10","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1172\/JCI117973","article-title":"Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis","volume":"95","author":"Balashov","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jocn.2007.09.016_bib11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jocn.2004.04.006","article-title":"Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain-Barre syndrome","volume":"12","author":"Csurhes","year":"2005","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2007.09.016_bib12","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/jnnp.2004.052282","article-title":"T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"76","author":"Csurhes","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2007.09.016_bib13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1568-9972(02)00054-X","article-title":"About CD4pos CD25pos regulatory cells","volume":"1","author":"Asseman","year":"2002","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jocn.2007.09.016_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2006.02348.x","article-title":"Regulatory T cells in human disease and their potential for therapeutic manipulation","volume":"118","author":"Taams","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.jocn.2007.09.016_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jocn.2007.09.016_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0165-5728(02)00400-9","article-title":"Expression ratios of the Bcl-2 family proteins and disease activity in multiple sclerosis","volume":"134","author":"Sharief","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2007.09.016_bib17","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1212\/WNL.55.7.906","article-title":"Fas(t) track to apoptosis in MS: TNF receptors may suppress or potentiate CNS demyelination","volume":"55","author":"Segal","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2007.09.016_bib18","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P","article-title":"Human anergic\/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population","volume":"31","author":"Taams","year":"2001","journal-title":"Eur J Immunol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586807006005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586807006005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T02:25:32Z","timestamp":1545877532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586807006005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0967586807006005"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2007.09.016","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}